Concerning cytosolic localization, we found that 69.9% (86/123) of the SCLC samples were positive, whereas 96.4% (27/28) of carcinoid samples were immunoreactive for inactive FOXM1 in the cytoplasm (p=0.004). The gene discussed is FOXM1; the disease is carcinoid tumor.